Evolution of steroids during pregnancy: Maternal, placental and fetal synthesis

Annales d'Endocrinologie

Volumn 77, Issue 2, 2016, Pages 82-89

  Morel, Yves ^a   Roucher, Florence ^a   Plotton, Ingrid ^a   Goursaud, Claire ^a   Tardy, Véronique ^a   Mallet, Delphine ^a  

^a CPBE   (France)

Author keywords

Androgens metabolism; Aromatase deficiency; CYP11A1 deficiency; enzymology metabolism; Estriol metabolism; Estrogens metabolism; Fetus ; Glucocorticoids metabolism; Gonadal steroid; Hormones biosynthesis ; Humans; metabolism; Placenta ; Pregnancy; Progesterone metabolism

Indexed keywords

ANDROGEN; CYTOCHROME P450 17; ESTROGEN; GLUCOCORTICOID; PROGESTERONE; STEROID HORMONE;

AMNION FLUID; ARTICLE; BIOSYNTHESIS; BIRTH; FOLLOW UP; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NIDATION; OBSTETRIC DELIVERY; PLACENTA; PREGNANCY; PREMATURE LABOR; STEROID METABOLISM; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; METABOLISM; PHYSIOLOGY;

ANDROGENS; ESTROGENS; FEMALE; FETUS; GLUCOCORTICOIDS; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY;

EID: 84964751101     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2016.04.023     Document Type: Article

References (71)

1. Yen S.S. Endocrine regulation of metabolic homeostasis during pregnancy. Clin Obstet Gynecol 1973, 16:130-147.
2. Tal R., Taylor H.S., Burney R.O., Mooney S.B., Giudice L.C. Endocrinology of pregnancy 2000, Endotext, South Dartmouth (MA). L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, A. et (Eds.).
3. Hill M., Paskova A., Kanceva R., Velikova M., Kubatova J., Kancheva L., et al. Steroid profiling in pregnancy: a focus on the human fetus. J Steroid Biochem Mol Biol 2014, 139:201-222.
4. Folligan K., Roume J., Razavi F., Sepaniak S., Bouvier R., Morel Y., et al. [Hypoplasia adrenal congenita of anencephalic type: two cases with pituitary abnormalities and review of literature.]. Morphologie 2011, 95:26-33.
5. Macdonald P.C., Siteri P.K. Origin of estrogen in women pregnant with an anencephalic fetus. J Clin Invest 1965, 44:465-474.
6. Forest M.G., Morel Y., David M. Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol Metab 1998, 9:284-289.
7. Watari H., Arakane F., Moog-Lutz C., Kallen C.B., Tomasetto C., Gerton G.L., et al. MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A 1997, 94:8462-8467.
8. Miller W.L. Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol 2013, 379:62-73.
9. Tuckey R.C. Progesterone synthesis by the human placenta. Placenta 2005, 26:273-281.
10. Morel Y., Roucher F., Plotton I., Simard J., Coll M.D. 3beta-hydroxysteroid dehydrogenase deficiency. Genetic steroid disorders 2013, 99-110. Elsevier. M.I. New (Ed.).
11. Thomas J.L., Berko E.A., Faustino A., Myers R.P., Strickler R.C. Human placental 3ß-hydroxy-5-ene-steroid dehydrogenase and steroid 5Æ 4-ene-isomerase: purification from microsomes, substrate kinetics, and inhibition by product steroids. J Steroid Biochem 1988, 31:785-793.
12. Luu-The V., Côté M., Labrie F. Purification of human placental 3ß-hydroxysteroid dehydrogenase/δ5-isomerase. Clin Invest Med 1988, 11:C200.
13. Cherradi N., Rossier M.F., Vallotton M.B., Timberg R., Friedberg I., Orly J., et al. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome p450scc and 3beta-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J Biol Chem 1997, 272:7899-7907.
14. Ferre F., Breuiller M., Cedard L. Human placental delta5-3beta hydroxysteroid dehydrogenase activity (delta5-3beta HSDH): intracellular distribution, kinetic properties, retroinhibition and influence of membrane delipidation. Steroids 1975, 26:551-570.
15. Saenger P., Klonari Z., Black S.M., Compagnone N., Mellon S.H., Fleischer A., et al. Prenatal diagnosis of congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 1995, 80:200-205.
16. Kim C.J., Lin L., Huang N., Quigley C.A., AvRuskin T.W., Achermann J.C., et al. Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 2008, 93:696-702.
17. Parajes S., Chan A.O., But W.M., Rose I.T., Taylor A.E., Dhir V., et al. Delayed diagnosis of adrenal insufficiency in a patient with severe penoscrotal hypospadias due to two novel P450 side-change cleavage enzyme (CYP11A1) mutations (p.R360W; p.R405X). Eur J Endocrinol 2012, 167:881-885.
18. Guran T., Buonocore F., Saka N., Ozbek M.N., Aycan Z., Bereket A., et al. Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort. J Clin Endocrinol Metab 2016, 101:284-292.
19. Tee M.K., Abramsohn M., Loewenthal N., Harris M., Siwach S., Kaplinsky A., et al. Varied clinical presentations of seven patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 2013, 98:713-720.
20. Pomahacova R., Sykora J., Zamboryova J., Paterova P., Varvarovska J., Subrt I., et al. First case report of rare congenital adrenal insufficiency caused by mutations in the CYP11A1 gene in the Czech Republic. J Pediatr Endocrinol Metab 2016, [pii:/j/jpem.ahead-of-print/jpem-2015-0255/jpem-2015-0255.xml]. 10.1515/jpem-2015-0255.
21. al Kandari H., Katsumata N., Alexander S., Rasoul M.A. Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46,XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. J Clin Endocrinol Metab 2006, 91:2821-2826.
22. Sahakitrungruang T., Soccio R.E., Lang-Muritano M., Walker J.M., Achermann J.C., Miller W.L. Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab 2010, 95:3352-3359.
23. Katsumata N., Ohtake M., Hojo T., Ogawa E., Hara T., Sato N., et al. Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 2002, 87:3808-3813.
24. Rubtsov P., Karmanov M., Sverdlova P., Spirin P., Tiulpakov A. A novel homozygous mutation in CYP11A1 gene is associated with late-onset adrenal insufficiency and hypospadias in a 46,XY patient. J Clin Endocrinol Metab 2009, 94:936-939.
25. Tajima T., Fujieda K., Kouda N., Nakae J., Miller W.L. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 2001, 86:3820-3825.
26. Parajes S., Kamrath C., Rose I.T., Taylor A.E., Mooij C.F., Dhir V., et al. A novel entity of clinically isolated adrenal insufficiency caused by a partially inactivating mutation of the gene encoding for P450 side chain cleavage enzyme (CYP11A1). J Clin Endocrinol Metab 2011, 96:E1798-E1806.
27. Hiort O., Holterhus P.M., Werner R., Marschke C., Hoppe U., Partsch C.J., et al. Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab 2005, 90:538-541.
28. Pasqualini J.R. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 2005, 97:401-415.
29. De Hertogh R., Thomas K., Hoet J.J., Vanderheyden I. Plasma concentrations of unconjugated estrone, estradiol-17beta and estriol, and HCS throughout pregnancy in diabetics and gestational diabetics. Diabetologia 1976, 12:455-461.
30. O'Shaughnessy P.J., Monteiro A., Bhattacharya S., Fraser M.J., Fowler P.A. Steroidogenic enzyme expression in the human fetal liver and potential role in the endocrinology of pregnancy. Mol Hum Reprod 2013, 19:177-187.
31. Voutilainen R., Miller W.L. Developmental expression of genes for the steroidogenic enzymes P450cc (20,22 desmolase), P450c17 (17 alpha hydroxylase/17,20 lyase) and P450c21 (21-hydroxylase) in the human fetus. J Clin Endocrinol Metab 1986, 63:1145-1150.
32. Duanmu Z., Weckle A., Koukouritaki S.B., Hines R.N., Falany J.L., Falany C.N., et al. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 2006, 316:1310-1317.
33. Bader D., Riskin A., Vafsi O., Tamir A., Peskin B., Israel N., et al. Alpha-fetoprotein in the early neonatal period-a large study and review of the literature. Clin Chim Acta 2004, 349:15-23.
34. Fowler P.A., Anderson R.A., Saunders P.T., Kinnell H., Mason J.I., Evans D.B., et al. Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary. J Clin Endocrinol Metab 2011, 96:1754-1762.
35. Morel Y., Roucher F., Mallet D., Plotton I. Genetic of gonadal determination. Ann Endocrinol (Paris) 2014, 75:32-39.
36. Fluck C.E., Pandey A.V. Steroidogenesis of the testis-new genes and pathways. Ann Endocrinol (Paris) 2014, 75:40-47.
37. Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011, 32:81-151.
38. Masarie K., Katz V., Balderston K. Pregnancy luteomas: clinical presentations and management strategies. Obstet Gynecol Surv 2010, 65:575-582.
39. Kanova N., Bicikova M. Hyperandrogenic states in pregnancy. Physiol Res 2011, 60:243-252.
40. Bulun S.E. Aromatase and estrogen receptor alpha deficiency. Fertil Steril 2014, 101:323-329.
41. Morel Y., Portrat-Doyen S., Nicolino M., Chatelain P., Forest M.G. Le gène de l'aromatase et sa pathologie héréditaire. Ref Gynecol Obstet 2001, 5:371-375.
42. Goto M., Brickwood S., Wilson D.I., Wood P.J., Mason J.I., Hanley N.A. Steroidogenic enzyme expression within the adrenal cortex during early human gestation. Endocr Res 2002, 28:641-645.
43. Goto M., Piper Hanley K., Marcos J., Wood P.J., Wright S., Postle A.D., et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 2006, 116:953-960.
44. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997, 18:378-403.
45. Narasaka T., Suzuki T., Moriya T., Sasano H. Temporal and spatial distribution of corticosteroidogenic enzymes immunoreactivity in developing human adrenal. Mol Cell Endocrinol 2001, 174:111-120.
46. Begeot M., Dubois M.P., Dubois P.M. Immunologic localization of alpha- and beta-endorphins and beta-lipotropin in corticotropic cells of the normal and anencephalic fetal pituitaries. Cell Tissue Res 1978, 193:413-422.
47. David M., Forest M.G. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediat 1984, 105:799-803.
48. Hanley N.A., Arlt W. The human fetal adrenal cortex and the window of sexual differentiation. Trends Endocrinol Metab 2006, 17:391-397.
49. Mendonca B.B., Leite M.V., de Castro M., Kino T., Elias L.L., Bachega T.A., et al. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 2002, 87:1805-1809.
50. Tardy-Guidollet V., Menassa R., Costa J.M., David M., Bouvattier-Morel C., Baumann C., et al. New management strategy of pregnancies at risk of Congenital Adrenal Hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011). J Clin Endocrinol Metab 2014, 99:1180-1188.
51. Forest M.G., David M., Morel Y. Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 1993, 45:75-82.
52. New M.I. Prenatal diagnosis and treatment of adrenogenital syndrome (steroid 21-hydroxylase deficiency). Dev Pharmacol Ther 1990, 15:200-210.
53. Folligan K., Bouvier R., Targe F., Morel Y., Trouillas J. [Histological and molecular study of fetal human adrenal cortex (12-36 wk)]. Ann Endocrinol (Paris) 2005, 66:519-526.
54. McMahon S.K., Pretorius C.J., Ungerer J.P., Salmon N.J., Conwell L.S., Pearen M.A., et al. Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 2010, 95:297-302.
55. Forest M.G., de Peretti E., Lecoq A., Cadillon E., Zabot M.T., Thoulon J.M. Concentration of 14 steroid hormones in human amniotic fluid of midpregnancy. J Clin Endocrinol Metab 1980, 51:816-822.
56. Paskova A., Parizek A., Hill M., Velikova M., Kubatova J., Duskova M., et al. Steroid metabolome in the umbilical cord: is it necessary to differentiate between arterial and venous blood?. Physiol Res 2014, 63:115-126.
57. Wudy S.A., Dorr H.G., Solleder C., Djalali M., Homoki J. Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentrations in fetuses at risk for 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999, 84:2724-2728.
58. Fahlbusch F.B., Heussner K., Schmid M., Schild R., Ruebner M., Huebner H., et al. Measurement of amniotic fluid steroids of midgestation via LC-MS/MS. J Steroid Biochem Mol Biol 2015, 152:155-160.
59. Plotton I., Ruet S., Rigaud C., Till M., Sanlaville D., Morel Y. Normal value of steroids in amniotic fluid by LC-MS/MS method. Horm Res Paediatr 2014, 82(Suppl. 1):69.
60. Reisch N., Idkowiak J., Hughes B.A., Ivison H.E., Abdul-Rahman O.A., Hendon L.G., et al. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency. J Clin Endocrinol Metab 2013, 98:E528-E536.
61. Shackleton C., Marcos J., Arlt W., Hauffa B.P. Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet 2004, 129A:105-112.
62. Bulun S.E. Aromatase deficiency and estrogen resistance: from molecular genetics to clinic. Semin Reprod Med 2000, 18:31-39.
63. Hameister H., Wolff G., Lauritzen C.H., Lehmann W.O., Hauser A., Ropers H.H. Clinical and biochemical investigations on patients with partial deficiency of placental steroid sulfatase. Hum Genet 1979, 46:199-207.
64. Mueller J.W., Gilligan L.C., Idkowiak J., Arlt W., Foster P.A. The regulation of steroid action by sulfation and desulfation. Endocr Rev 2015, 36:526-563.
65. Kratz L.E., Kelley R.I. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet 1999, 82:376-381.
66. Pelissier P., Merlin E., Prieur F., David M., Malpuech G., Forest M.G., et al. [Adrenal hypoplasia congenita: four new cases in children]. Arch Pediatr 2005, 12:380-384.
67. Malpuech G., Vanlieferinghen P., Dechelotte P., Gaulme J., Labbe A., Guiot F. Isolated familial adrenocorticotropin deficiency: prenatal diagnosis by maternal plasma estriol assay. Am J Med Genet 1988, 29:125-130.
68. Marshall I., Ugrasbul F., Manginello F., Wajnrajch M.P., Shackleton C.H., New M.I., et al. Congenital hypopituitarism as a cause of undetectable estriol levels in the maternal triple-marker screen. J Clin Endocrinol Metab 2003, 88:4144-4148.
69. Lepinard C., Coutant R., Boussion F., Loisel D., Delorme B., Biquard F., et al. Prenatal diagnosis of absence of the septum pellucidum associated with septo-optic dysplasia. Ultrasound Obstet Gynecol 2005, 25:73-75.
70. Merkatz I.R., New M.I., Peterson R.E., Seaman M.P. Prenatal diagnosis of adrenogenital syndrome by amniocentesis. J Pediatr 1969, 75:977-982.
71. Dhayat N.A., Frey A.C., Frey B.M., d'Uscio C.H., Vogt B., Rousson V., et al. Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: Tracing the complexity of human postnatal steroidogenesis. J Steroid Biochem Mol Biol 2015, 154:226-236.